Home › Nivalis Therapeutics A No-Brainer For Biotech Investors
 

Keywords :   


Nivalis Therapeutics A No-Brainer For Biotech Investors

2015-06-15 22:09:24| Biotech - Topix.net

Nivalis Therapeutics is a mid-clinical trial stage pharmaceutical company working with therapies that target certain gene mutations in cystic fibrosis patients. The company is preparing for its initial public offering to raise funds for continuing clinical trials and research.

Tags: investors biotech therapeutics nobrainer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Tropical Storm Milton Public Advisory Number 2
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 26
05.10Tropical Storm Milton Graphics
05.10Hurricane Kirk Wind Speed Probabilities Number 26
05.10Hurricane Leslie Graphics
05.10Hurricane Kirk Public Advisory Number 26
05.10Summary for Hurricane Kirk (AT2/AL122024)
More »